Potential Drug Targets for Stress Urinary Incontinence

109 plasma proteins were identified as associated with stress urinary incontinence (SUI) in women, narrowed to 10 core targets. Five promising drugs were found, with the compound para-benzoquinone showing the strongest predicted binding to three key proteins. This dataset supports drug repurposing research for a common condition where current treatments are often ineffective or have adverse side effects.

Use Cases

• Prioritizing drug candidates for repurposing based on predicted protein binding from computational simulations.
• Validating genetic associations between plasma proteins and stress urinary incontinence using Mendelian Randomization results.
• Investigating the biological network of 10 core proteins to understand the pathophysiology of stress urinary incontinence.
• Screening existing drugs or supplements (e.g., CoQ10 derivatives) for potential therapeutic effects on specific protein targets.

Strengths

• Dataset is derived from a large-scale analysis of genetic and health data, identifying 109 associated proteins.
• Results are publicly available under a permissive CC-BY-4.0 license, facilitating reuse and sharing.
• Analysis employs a multi-method approach combining Mendelian Randomization and network pharmacology.

Limitations

• Column names and exact row counts are not provided, limiting understanding of the dataset's structure.
• The primary findings are computational and require laboratory testing and clinical studies for validation.
• The dataset's provenance and the specific source of the genetic and health data are not detailed.

Provenance

Source

Author: chen li

Collection Method

Analysis likely involves Mendelian Randomization of genetic data and network pharmacology for drug screening.

Freshness

Last updated on 2026-03-18.